MedPath

Combination of Etoricoxib and Low Pressure Pneumoperitoneum versus Standard Treatment for the Management of Pain after Laparoscopic Cholecystectomy: A Double-Blind Randomized Controlled Trial

Phase 4
Completed
Conditions
Patients with gallstone who underwent laparoscopic cholecystectomy
Etoricoxib
Low pressure
Standard pressure
Pneumoperitoneum
Laparoscopic cholecystectomy
Registration Number
TCTR20140213001
Lead Sponsor
Royal College of Surgeons of Thailand
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
120
Inclusion Criteria

ASA 1-2 patients age 18-75 years requiring elective laparoscopic cholecystectomy were eligible for enrollment in the study.

Exclusion Criteria

1) Acute preoperative pain other than biliary colic
2) Require chronic pain treatment
3) Advanced renal disease (creatinine clearance < 30 ml/min)
4) Heart failure or fluid retention
5) Using preoperative NSAIDs or opioids within 24 hours of the schedule operation
6) A known hypersensitivity to NSAIDs
7) Pregnant patients
8) Morbid obesity (BMI > 35 kg/m2)
9) Contraindication for etoricoxib such as ischemic heart disease, severe hepatic impairment (Child-Pugh score > 9), lactating patient

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Pain score at rest and on movement At 1&#44; 2 hours postoperatively&#44; and then every 4 hours until discharge Numeric rating scale (0&#45;10)
Secondary Outcome Measures
NameTimeMethod
analgesic drug use At 1&#44; 2 hours postoperatively&#44; and then every 4 hours until discharge Record rescuse drug
© Copyright 2025. All Rights Reserved by MedPath